Synbiotic capsules for adults on peritoneal dialysis
Official title: Impact of Synbiotic Supplementation in Peritoneal Dialysis Patients
Run by Hospital Universitario Dr. Jose E. Gonzalez · NCT07694791 · Data updated 2026-11-12
This study tests whether daily synbiotic capsules can reduce inflammation and improve nutrition in adults with CKD on peritoneal dialysis compared with a placebo.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Hospital Universitario Dr. Jose E. Gonzalez Academic / other |
| Locations | 1 site (Monterrey, Nuevo León) |
| Status | Recruiting |
| Started | October 3, 2025 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | July 10, 2026 |
| Trial ID | NCT07694791 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 and older with CKD on home peritoneal dialysis for at least 1 month are eligible.
✕Probably not a fit
Patients who do not respond biologically or who do not meet follow-up requirements may see no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this randomized, double-blind trial, adults on home peritoneal dialysis will receive daily synbiotic capsules or an identical placebo for six months. Researchers will measure inflammatory markers (CRP, ESR), uremic toxins (p-cresol, indoxyl sulfate), and malnutrition-inflammation status, plus track peritonitis episodes. Participants will have visits at baseline, 3 months, and 6 months for blood tests and nutritional assessments. The aim is to determine if synbiotics can improve gut-related biomarkers and clinical outcomes in this patient group.
Why it matters
Potential benefit: If successful, synbiotics could lower inflammation and possibly reduce infection risk and improve nutrition for people on peritoneal dialysis.
How similar studies have gone: Previous similar gut-targeted interventions have shown promise in CKD populations, but results are variable and this exact synbiotic combination is being tested in this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 years or older. * Patients diagnosed with kidney disease who have been receiving peritoneal dialysis at home for at least 1 month. Exclusion Criteria: * Patients who are unable to eat or receive food through a feeding tube. * Patients who have taken prebiotics or probiotics (supplements that support gut health) in the month before the study starts. * Patients who used antibiotics in the month before the study starts. * Patients who cannot attend the scheduled follow-up visits (missing the second follow-up appointment will result in being removed from the study). * Note on non-adherence and withdrawal: Patients who are unable to take their assigned capsules regularly (taking less than 80% of the total capsules will result in being removed from the study).
Where it's running
-
Hospital Universitario Dr. José E. González, Centro Regional de Enfermedades Renales (CRER)
Monterrey, Nuevo León, Mexico Recruiting
Study contacts
- Principal investigator: Elisa María Guadalupe Guerrero González, MD — Hospital Universitario. Dr. José Eleuterio González
- Study coordinator: Elisa María Guadalupe Guerrero González, MD
- Email: eguerrerog@uanl.edu.mx
- Phone: 528182803788
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Guiding Optimal Blood Pressure in Peritoneal Dialysis
This pilot tests whether aiming for a lower systolic blood pressure target (<120 mmHg) is feasible and practical for adults with end-stage kidney disease on peritoneal dialysis, compared to a <140 mmHg target.
-
Primary Palliative Care: A Feasibility Project for Family Health Units
This feasibility trial tests a GP training program plus a structured 12-week palliative-care visit plan to see if it can be carried out in primary care for adults with advanced illness.
-
Potassium-friendly plant-based diet for people with advanced CKD
This pilot study tests whether a liberal plant-based diet with normal potassium levels is safe and acceptable for adults with advanced CKD (eGFR <30) who are not on dialysis.
-
Herbal Medicine Use in CKD Patients on Réunion Island
This study tests how common herbal medicine use is among adults with chronic kidney disease (stages 3–5) on Réunion Island and whether it relates to kidney disease progression over a year.
-
Storing deceased donor kidneys at 10°C instead of on ice (4°C)
This trial will try to see if deceased donor kidneys stored at 10°C help adult transplant recipients have better kidney function after transplant compared with kidneys stored on ice (4°C).
-
MiDiálisis mobile app with Bluetooth scale and smartband for people on peritoneal dialysis
This pilot will try a smartphone app plus a Bluetooth scale and smartband to help adults on peritoneal dialysis track weight, vitals, and activity and share the data with their care team.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.